ЮРАК-ҚОН ТОМИР КАСАЛЛИКЛАРИ БЎЛГАНЛАРДА COVID-19 КОРОНАВИРУС ИНФЕКЦИЯСИНИНГ ЗАМОНАВИЙ ЛАБОРАТОР АҲАМИЯТИ
Keywords:
Калит сўзлар: COVID-19, юрак-қон томир касалликлари, тропонин I, Д- димер, цитокинлар.Abstract
АННОТАЦИЯ
Юрак-қон томир патологиялари мавжуд бўлган беморларда SARS-CoV-2
инфекциясининг клиник кечиши тизимли гомеостазнинг кескин бузилиши билан
характерланади. Бундай шароитда анъанавий диагностика усуллари миокард
деструкцияси ва қон томир эндотелийсидаги яширин силжишларни ҳар доим ҳам
вақтида кўрсатиб бера олмайди. Шу сабабли, янги авлод юқори сезувчанликка
эга биомаркерлар мажмуасини ўрганиш алоҳида илмий-амалий аҳамият касб
этади.
Юрак-қон томир касалликлари (ЮҚТК) фонида COVID-19 инфекцияси
билан оғриган беморларда замонавий лаборатор кўрсаткичларнинг диагностик
ва прогностик қийматини мажмуавий баҳолаш.
References
Фойдаланилган адабиётлар рўйхати
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult
inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020;395(10229):1054–1062.
2. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of
patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology.
2020;5(7):811–818.
3. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in
hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiology.
2020;5(7):802–810.
4. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease.
Circulation. 2020;141(20):1648–1655.
5. Bansal M. Cardiovascular disease and COVID-19. Diabetes & Metabolic
Syndrome: Clinical Research & Reviews. 2020;14(3):247–250.
6. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of
coronaviruses on the cardiovascular system: a review. JAMA Cardiology.
2020;5(7):831–840.
7. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for
patients, health care workers, and health systems during the COVID-19
pandemic. Journal of the American College of Cardiology. 2020;75(18):2352–
2371.
8. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with
coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.
Progress in Cardiovascular Diseases. 2020;63(3):390–391.
9. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated
with poor prognosis in patients with novel coronavirus pneumonia. Journal of
Thrombosis and Haemostasis. 2020;18(4):844–847.
10. European Society of Cardiology (ESC). ESC guidance for the diagnosis and
management of cardiovascular disease during the COVID-19 pandemic.
European Heart Journal. 2020;41(19):1805–1807.
11. World Health Organization. Clinical management of COVID-19: Interim
guidance. WHO; 2020.
